+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
512036 SKYBIOTECH

Skybiotech Healthcare Share Price

 

 

Skybiotech Healthcare live price: ₹161.5. It opened at ₹162 vs previous close ₹170; intraday high/low: ₹162/₹162. The 50 & 200 DMA stand at ₹165.77/₹173.38.

Skybiotech Healthcare Performance

  • Today's Low
  • ₹162
  • Today's High
  • ₹162
  • 52 Week Low
  • ₹116
  • 52 Week High
  • ₹237
  • Open Price₹162
  • Previous Close₹170
  • Volume5
  • 50 DMA₹165.77
  • 100 DMA₹167.00
  • 200 DMA₹173.38

Skybiotech Healthcare Chart

Investment Returns

  • Over 1 Month -13.17%
  • Over 3 Month + 10.47%
  • Over 6 Month -2.12%
  • Over 1 Year -18.04%

Smart Investing Starts Here Start SIP with Skybiotech Healthcare for Steady Growth!

Invest Now

Skybiotech Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -27.7
  • PEG Ratio
  • -0.5
  • Market Cap Cr
  • 31
  • P/B Ratio
  • 3.9
  • Average True Range
  • 7.65
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 9.72
  • RSI
  • 43.18
  • MFI
  • 70.4

Skybiotech Healthcare Financials

Skybiotech Healthcare Technicals

EMA & SMA

Current Price
₹161.50
-8.5 (-5%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹175.00
  • 50 Day
  • ₹165.80
  • 100 Day
  • ₹167.00
  • 200 Day
  • ₹173.40

Resistance and Support

161.5 Pivot Speed
  • R3 161.50
  • R2 161.50
  • R1 161.50
  • S1 161.50
  • S2 161.50
  • S3 161.50

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Skybiotech Healthcare Ltd has an operating revenue of Rs. 7.10 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of -23% needs improvement, ROE of -13% is poor and needs improvement. The company has a high debt to equity of 103%, which can be a reason to worry. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 58 indicates it belongs to a fair industry group of Apparel-Clothing Mfg and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Skybiotech Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-30 Audited Results
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-28 Increase in Authorised Capital
2025-08-14 Quarterly Results

Skybiotech Healthcare Shareholding Pattern

63.48%
34.65%
1.87%

Skybiotech Healthcare FAQs

Skybiotech Healthcare share price is ₹161 As on 11 July, 2026 | 19:49

The Market Cap of Skybiotech Healthcare is ₹30.9 Cr As on 11 July, 2026 | 19:49

The P/E ratio of Skybiotech Healthcare is -27.7 As on 11 July, 2026 | 19:49

The PB ratio of Skybiotech Healthcare is 3.9 As on 11 July, 2026 | 19:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23